The demand for a COVID-19 vaccine
Economics & Human Biology, 2022, vol. 46, issue C
Taking willingness to pay as primitive, this paper establishes an analytical framework for demand estimation, where the estimator is robust to endogeneity of price. Applying the framework, this paper then estimates demand functions for a COVID-19 vaccine and compute the consumer surplus in both China and the UAE. We find that the price elasticities of demand are mostly greater than one in both countries. An elastic demand suggests subsidy is likely to be successful in promoting vaccination. The consumer surplus is sizeable, around 58 billion US$ in China and 646 million US$ in the UAE. The figures can inform policymakers in assessing their vaccine programs.
Keywords: Demand for vaccine; Demand estimation; Willingness to pay; COVID-19; Contingent valuation; China; UAE (search for similar items in EconPapers)
JEL-codes: D12 I12 (search for similar items in EconPapers)
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
Full text for ScienceDirect subscribers only
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:eee:ehbiol:v:46:y:2022:i:c:s1570677x22000314
Access Statistics for this article
Economics & Human Biology is currently edited by J. Komlos, Inas R Kelly and Joerg Baten
More articles in Economics & Human Biology from Elsevier
Bibliographic data for series maintained by Catherine Liu ().